This randomized controlled trial, published in the International Journal of Dermatology (1992, PMID: 1428436), evaluated the effectiveness and safety of 2% topical minoxidil in 33 women aged 22 to 44 with Ludwig's grade I or II female androgenetic alopecia. Over a 32-week period, participants using minoxidil saw an average increase
